Governance at a Glance

Chair
Member
Board Members Audit Compensation Nominating and Corporate Governance

Sharon Barbari

Jay Birnbaum

Jerry McLaughlin

Bubba Sandford

Phillipe Weigerstorfer

Committee Charters

Sharon Barbari

Ms. Barbari has served as Executive Vice President of Finance and Chief Financial Officer of Cytokinetics Inc. since July 2009. She served as Senior Vice President of Finance and Chief Financial Officer from September 2004 through June 2009. From September 2002 to August 2004, Ms. Barbari served as Chief Financial Officer and Senior Vice President of Finance and Administration of InterMune, Inc., a biopharmaceutical company. From January 1998 to June 2002, she served at Gilead Sciences, Inc., a biopharmaceutical company, and held several positions of increasing responsibility including most recently as its Vice President and Chief Financial Officer. From 1996 to 1998, Ms. Barbari served as Vice President of Strategic Planning at Foote, Cone & Belding Healthcare in San Francisco, an international advertising and marketing firm. From 1972 to 1995, she was employed by Syntex Corporation where she held various management positions in corporate finance, financial planning, marketing and commercial planning.

Jay Birnbaum

Jay Birnbaum has served as a director since April 2007. Dr. Birnbaum is a co-founder and former Chief Medical Officer of Kythera Biopharmaceuticals and a co-founder and Chief Scientific Officer of Hallux, Inc. Prior to starting his own consulting company in 1999, he was Vice President, Global Project Management, at Novartis Pharmaceuticals, where he also had responsibilities for strategic planning and development of the company's dermatology portfolio. Previously, he held various management positions at Sandoz/Novartis and at both the Medical and Consumer Product Divisions of American Cyanamid Company (Wyeth). In addition to his consulting practice, he is currently Executive Vice President Global Product Development at Thesan Pharmaceuticals. He has served on the board of directors of Excaliard Pharmaceuticals (acquired by Pfizer) and on the scientific advisory boards of several companies.

He received both an M.S. and Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.

Jerry McLaughlin

Mr. McLaughlin served as Interim Chief Executive Officer of Applied BioCode, Inc. from November 2011 to April 2013. In April 2011, he also founded and currently serves as Chairman and Chief Executive Officer, of DataStream Medical Imaging Systems, Inc., a start-up to develop diagnostic imaging software applications that work in conjunction with existing digital radiology platforms. He previously served as President of DataFlow Information Systems, from July 2007 to December 2011, and President and Chief Executive Officer of CompuMed, Inc. from May 2002 to June 2007. Mr. McLaughlin also serves on the board of directors of DataStream Medical Imaging Systems, Inc., a private company in the medical imaging software industry.

Bubba Sandford

Mr. Sandford has over 30 years of leadership experience as CEO, President, or General Manager, guiding businesses in various stages, including startups, turnarounds and wind downs.  Most recently Mr. Sandford served as President and CEO of Command Center Inc, a publicly traded national temporary staffing firm with 67 offices in 22 states, where he led the successful turnaround resulting in record metrics in every category especially industry leading gross margins, EBITDA, cash and risk management.  He has led companies in diverse industries, including technology, industrial fabrication, security services, waste management and retail. Prior to Command Center, he served as an independent consultant to Silicon Valley venture capitalists. From 2003-2005, he led the restructuring of The Environmental Trust, a land mitigation organization with 80 holdings, resulting in significant asset protection.  He earned a BA in Psychology from the University of Massachusetts at Amherst.  Mr. Sandford was awarded a full fellowship and earned his MBA from Cornell University while serving as the CEO of Student Agencies, America’s oldest student-run company. He is a former U.S. Navy SEAL.

Phillipe Weigerstorfer

Mr. Weigerstorfer brings extensive pharmaceutical and dermatology experience to Sonoma's board with a track record of expanding businesses around the globe. He began his career in marketing at Sandoz and Novartis, advancing to marketing and business leader roles for cardiovascular, dermatology and other global business units. During this time, he helped develop and launch highly successful brands such as Lamisil, Apligraf and Elidel. In 1999, Weigerstorfer joined Galencia Ltd's executive team where he led the retail, pre-wholesale, business development and M&A divisions. Philippe was a key leader in transforming Galencia from a Swiss-based wholesaler to a player in the international healthcare market.